Pituitary & hypothalamus

Giant prolactinomas, a detailed analysis of 196 adult cases

PituitaryPublished Systematic review of published cases

An erratum to this article was published (Pituitary, 3 Jan 2025 ↗)

Authors' conclusion

Giant prolactinomas are rare and have a male predominance. Visual impairment is the most frequent presenting symptom in men and amenorrhea in women. The gender-related difference in tumor size and level of prolactin was confirmed in this analysis where men had a larger diameter and a higher baseline prolactin level. DAs are the treatment of choice, irrespective of tumor size and presence of visual impairment. As only half of the cases achieved normoprolactinemia we do not, in contrast to previous literature, state giant prolactinomas to be exquisitely sensitive to DAs. Patient characteristics associated with persistent hyperprolactinemia after treatment with a DA were female gender, higher baseline prolactin and larger tumor size . This analysis did show TSH- and ACTH-deficiency to be more frequent after surgery which was not seen for LH/FSH deficiency.

Study context

Population
Adults with giant prolactinoma (diameter ≥ 40 mm, prolactin > 1000 ng/ml, no concomitant GH/ACTH secretion); age 38 (28–50) years, F/M ratio 1/3.6
Participants
196 published cases
Comparison
Men vs women
Outcome
Clinical characteristics and DA outcomes
Methodological detailsstructured literature search, men vs women comparison
  • Structured literature search
  • Men vs women comparison

Pooled result

As reported in the abstract

Median tumor diameter
53 (43-69) mm
Pituitary deficiency
91%
First-line dopamine agonist (DA) treatment
82%
Normoprolactinemia with first-line DA
51%
Tumor shrinkage with first-line DA
88%
Visual improvement with first-line DA
85%
Surgery performed
29%

Further pooled results

Presenting symptoms by sex

Visual impairment in men
73%
Headache in men
50%
Amenorrhea in women
58%

Women vs men at diagnosis and outcome

Women had a lower prolactin level and a smaller tumor diameter at diagnosis, but more frequent pituitary deficiencies and worse outcome

Original publication

Giant prolactinomas, a detailed analysis of 196 adult cases. Pituitary. Published 7 August 2023. doi:10.1007/s11102-023-01337-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.